Press releases Image EN FR Proton Therapy / 22.05.2023 IBA signs Binding Term Sheet with Medtechnica Ltd for two Proteus®ONE proton therapy solutions at the Tel Aviv Sourasky Medical Center in Israel Read more IBA signs Binding Term Sheet with Medtechnica Ltd for two Proteus®ONE proton therapy solutions at the Tel Aviv Sourasky Medical Center in Israel
Press releases Image EN FR Corporate / 17.05.2023 IBA Business Update – First Quarter 2023 Read more IBA Business Update – First Quarter 2023
Press releases Image EN FR RadioPharma Solutions / 16.05.2023 IBA Launches AKURACY®, an Integrated Solution for Cardiac PET Imaging at EACVI Meeting in Barcelona Read more IBA Launches AKURACY®, an Integrated Solution for Cardiac PET Imaging at EACVI Meeting in Barcelona
Press releases Image EN FR Dosimetry / 13.05.2023 IBA Launches Latest Radiation Therapy Quality Assurance Offerings at ESTRO 2023 Read more IBA Launches Latest Radiation Therapy Quality Assurance Offerings at ESTRO 2023
Brochures Image FR EN Corporate / 02.05.2023 IBA Corporate Brochure 2023 Read more IBA Corporate Brochure 2023
Press releases Image EN FR Corporate / 21.04.2023 IBA First Quarter 2023 Business Update – Date Change Read more IBA First Quarter 2023 Business Update – Date Change
Presentations Image EN Corporate / 23.03.2023 IBA Full Year 2022 Results Press Release Publication Date & Conference Call Details Read more IBA Full Year 2022 Results Press Release Publication Date & Conference Call Details
Press releases Image FR EN Corporate / 23.03.2023 IBA Reports Full Year 2022 Results Read more IBA Reports Full Year 2022 Results
Press releases Image EN FR Corporate / 14.03.2023 IBA is looking for 100 new collaborators in Belgium by June 2023 Read more IBA is looking for 100 new collaborators in Belgium by June 2023
Press releases Image EN FR Corporate / 20.02.2023 IBA Notice of Full Year 2022 Results and Conference Call Read more IBA Notice of Full Year 2022 Results and Conference Call
Press releases Image EN FR Proton Therapy / 10.01.2023 IBA announces contract with Moffitt Cancer Center for a Proteus®ONE proton therapy solution in Florida, US Read more IBA announces contract with Moffitt Cancer Center for a Proteus®ONE proton therapy solution in Florida, US
Press releases Image EN Proton Therapy / 20.12.2013 Major Milestone reached at Provision Center for Proton Therapy Read more Major Milestone reached at Provision Center for Proton Therapy
Press releases Image EN Proton Therapy / 17.12.2013 Beam ON for Proteus®ONE at Willis-Knighton Cancer Center Read more Beam ON for Proteus®ONE at Willis-Knighton Cancer Center
Press releases Image EN FR Corporate / 11.12.2013 IBA and SK Capital reach agreement on a full and final settlement for all outstanding claims and counterclaims regarding IBA Molecular Read more IBA and SK Capital reach agreement on a full and final settlement for all outstanding claims and counterclaims regarding IBA Molecular
Press releases Image EN Proton Therapy / 27.11.2013 IBA receives FDA clearance for its new Imaging Suite, a solid foundation for the development of future Image-Guided Proton Therapy (IGPT) solutions Read more IBA receives FDA clearance for its new Imaging Suite, a solid foundation for the development of future Image-Guided Proton Therapy (IGPT) solutions
Press releases Image EN FR Corporate / 18.11.2013 IBA Completes the Sale of Cisbio Bioassays Read more IBA Completes the Sale of Cisbio Bioassays
Press releases Image EN FR Corporate / 13.11.2013 IBA Trading Update - Third Quarter 2013 Read more IBA Trading Update - Third Quarter 2013
Press releases Image EN FR RadioPharma Solutions / 04.11.2013 IBA to Install the First Commercial 70 MeV Cyclotron Dedicated to the Production of Radiopharmaceuticals in the United States Read more IBA to Install the First Commercial 70 MeV Cyclotron Dedicated to the Production of Radiopharmaceuticals in the United States
Press releases Image EN FR Corporate / 25.10.2013 Evolution of the number of shares, voting rights and subscription rights Read more Evolution of the number of shares, voting rights and subscription rights